International Journal of Gerontology
Volume 1, Issue 1 , Pages 22-30, March 2007

Current Opinion on the Clinical Approach to the Diagnosis of Mitochondrial Disease

  • Peterus Thajeb

      Affiliations

    • Department of Neurology, Mackay Memorial Hospital, Taipei, Taiwan
    • National Yang-Ming University School of Medicine, Taipei, Taiwan
    • Taipei Medical University, Taipei, Taiwan
    • Corresponding Author InformationCorrespondence to: Dr Peterus Thajeb, Mackay Memorial Hospital, National Yang-Ming University School of Medicine, and Taipei Medical University, PO Box Nei-hu 6-30, Taipei 11499, Taiwan
    • ,
  • Dao-Fu Dai

      Affiliations

    • Department of Pathology, University of Washington School of Medicine, Seattle, USA

Accepted 11 November 2006.

Article Outline

SUMMARY 

Knowing the molecular basis of mitochondria, the aging process of the mitochondrial machinery and recognition of its disorders are becoming more important in modern medicine. The diagnosis of mitochondrial disease (MtD) is possible only when one is aware of it. The heterogeneity of MtD in terms of its phenotype expression and genotype variations makes MtD very unique. Current opinion on the clinical approach to patients with suspected mitochondrial disorders are highlighted in this review.

Key Words:  aging , mitochondrial disease , mitochondrial DNA , mutation , nuclear DNA , oxidative phosphorylation

No full text is available. To read the body of this article, please view the PDF online.

 

Back to Article Outline

References 

  1. Nass MM , Nass S . Intramitochondrial fibers with DNA characteristics. I. Fixation and electron staining reactions . J Cell Biol . 1963;19:593–611
  2. Anderson S , Bankier AT , Barrell BG , deBruijn MH , Coulson AR , Drouin J , et al.   Sequence and organization of human mitochondrial genome . Nature . 1981;290:457–465
  3. Shapira Y , Harel S , Russell A . Mitochondrial encephalomyopathies: a group of neuromuscular disorders with defects in oxidative metabolism . Isr J Med Sci . 1977;13:161–164
  4. Shoffner JM , Wallace DC . Oxidative phosphorylation diseases. Disorders of two genomes . In:  Harris H ,  Hirschhorn K editor. Advances in Human Genetics . New York: Plenum; 1970;p. 267–330 19
  5. Holt IJ , Harding AE , Morgan-Hughes JA . Deletions of muscle mitochondrial DNA in patients with mitochondrial myopathies . Nature . 1988;331:717–719
  6. DiMauro S , Tonin P , Servidei S . Metabolic myopathies . In:  Rowland LP ,  DiMauro S editor. Myopathies, Handbook of Clinical Neurology . Amsterdam: Elsevier Science Publishers B.V.; 1992;p. 496–497 18
  7. Morgan-Hughes JA . Mitochondrial diseases . In:  Engel AG ,  Franzini-Armstrong C editor. 2 nd edition. Myology . vol. 2: New York: McGraw-Hill; 1994;p. 1622–1623
  8. Luft R , Ikkos D , Palmieri G , Emster L , Afzelius B . A case of severe hypermetabolism of nonthyroid origin with a defect in the maintenance of mitochondrial respiratory control: a correlated clinical, biochemical, and morphological study . J Clin Invest . 1962;41:1776–1804
  9. DiMauro S , Gurgel-Giannetti J . The expanding phenotype of mitochondrial myopathy . Curr Opin Neurol . 2005;18:538–542
  10. Schapira AH , Cooper JM , Morgan-Hughes JA , Landon DN , Clark JB . Mitochondrial myopathy with a defect of mitochondrial protein transport . N Engl J Med . 1990;323:37–42
  11. Thajeb P , Dai D , Chiang MF , Shyu WC . Genotypephenotype correlation of maternally inherited disorders due to mutations in mitochondrial DNA . Taiwan J Obstet Gynecol . 2006;45:201–207
  12. Moraes CT , DiMauro S , Zeviani M , Lombes A , Shanske S , Miranda AF , et al.   Mitochondrial DNA deletions in progressive external ophthalmoplegia and Kearns-Sayre syndrome . N Engl J Med . 1989;320:1293–1299
  13. Wallace DC , Lott MT , Brown MD , Kerstann K . Mitochondria and neuroophthalmologic diseases . In:  Scriver CR ,  Beaudet AL ,  Sly WS ,  Valle D editor. The Metabolic and Molecular Basis of Inherited Disease . 8 th edition. New York: McGraw-Hill; 2001;p. 2425–2509 2
  14. Liou CW , Huang CC , Chee EC , Jong YJ , Tsai JL , Pang CY , et al.   MELAS syndrome: correlation between clinical features and molecular genetic analysis . Acta Neurol Scand . 1994;90:354–359
  15. Thajeb P , Lee HC , Pang CY , Jeng CM , Huang SF , Wei YH . Phenotypic heterogeneity in a Chinese family with mitochondrial disease and A3243G mutation of mitochondrial DNA . Chin Med J (Taipei) . 2000;63:71–76
  16. Hammans SR , Sweeney MG , Hanna MG , Brockington M , Morgan-Hughes JA , Harding AE . The mitochondrial DNA transfer RNALeu(UUR) A to G(3243) mutation. A clinical and genetic study . Brain . 1995;118:721–734
  17. McFarland R , Taylor RW , Turnbull DM . The neurology of mitochondrial DNA disease . Lancet Neurol . 2002;1:343–351
  18. Shoffner JM , Lott MT , Voljavec AS , Soueidan SA , Costigan DA , Wallace DC . Spontaneous Kearns-Sayre/chronic external ophthalmoplegia plus syndrome associated with a mitochondrial DNA deletion: a slip-replication model and metabolic therapy . Proc Natl Acad Sci USA . 1989;86:7952–7956
  19. Kearns TP , Sayre GP . Retinitis pigmentosa, external ophthalmoplegia and complete heart block . Ophthalmology . 1958;60:280–289
  20. Shoffner JM , Wallace DC . Oxidative phosphorylation diseases . In:  Scriver CR ,  Beaudet AL ,  Sly WS ,  Valle D editor. The Metabolic and Molecular Basis of Inherited Disease . New York: McGraw-Hill; 1995;p. 1535–1609
  21. Seneca S , Verhelst H , De Meirleir L , Meire F , CeuterickDe Groote C , Lissens W , et al.   A new mitochondrial point mutation in the transfer RNA(Leu) gene in a patient with a clinical phenotype resembling Kearns-Sayre syndrome . Arch Neurol . 2001;58:1113–1118
  22. Lerman-Sagie T , Leshinsky-Silver E , Watemberg N , Luckman Y , Lev D . White matter involvement in mitochondrial diseases . Mol Genet Metab . 2005;84:127–136
  23. Moraes CT , Zeviani M , Schon EA , Hickman RO , Vlcek BW , DiMauro S . Mitochondrial DNA deletion in a girl with manifestations of Kearns-Sayre and Lowe syndromes: an example of phenotypic mimicry? . Am J Med Genet . 1991;41:301–305
  24. Moraes CT , Shanske S , Tritschler HJ , Aprille JR , Andreetta F , Bonilla E , et al.   mtDNA depletion with variable tissue expression: a novel genetic abnormality in mitochondrial disease . Am J Hum Genet . 1991;48:492–501
  25. Servidei S . Mitochondrial encephalomyopathies: gene mutation . Neuromuscul Disord . 2004;14:107–116
  26. Man PY , Turnbull DM , Chinnery PF . Leber hereditary optic neuropathy . J Med Genet . 2002;39:162–169
  27. Lev D , Yanoov-Sharav M , Watemberg N , Leshinsky-Silver E , Lerman-Sagie T . White matter abnormalities in Leber's hereditary optic neuropathy due to the 3460 mitochondrial DNA mutation . Eur J Paediatr Neurol . 2002;6:121–123
  28. Pavlakis SG , Phillips PC , DiMauro S , deVivo DC , Rowland LP . Mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes: a distinctive clinical syndrome . Ann Neurol . 1984;16:481–488
  29. Ciafaloni E , Ricci E , Shanske S , Moraes CT , Silvestri G , Hirano M , et al.   MELAS: clinical features, biochemistry, and molecular genetics . Ann Neurol . 1992;31:391–398
  30. Abe K . Cerebral lactic acidosis correlates with neurological impairment in MELAS . Neurology . 2004;63:2458
  31. Thajeb P , Huang KM , Chi EY , Shih CC , Su ML , Huang JS . Koshevnikov syndrome in a patient with MELAS plus syndrome: electron microscopic and neuroimage studies . Chin Med J (Beijing) . 1997;110:726–730
  32. Finsterer J , Kopsa W . Basal ganglia calcification in mitochondrial disorders . Metab Brain Dis . 2005;20:219–226
  33. Apostolova LG , White M , Moore SA , Davis PH . Deep white matter pathologic features in watershed regions: a novel pattern of central nervous system involvement in MELAS . Arch Neurol . 2005;62:1154–1156
  34. Peng NJ , Liu RS , Li JY , et al.   Increased cerebral blood flow in MELAS shown by Tc-99m HMPAO brain SPECT . Neuroradiology . 2000;42:26–29
  35. Thajeb P , Wu MC , Shih BF , Tzen CY , Chiang MF , Yuan RY . Brain SPECT studies in patients with A3243G mutation of the mitochondrial DNA . Ann NY Acad Sci . 2005;1042:48–54
  36. Tokunago M , Mita S , Sakuta R , Nonaka I , Araki S . Increased mitochondrial DNA in blood vessels and ragged-red fibers in mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes (MELAS) . Ann Neurol . 1993;33:275–280
  37. Goto Y , Nonaka I , Horai S . A mutation in the tRNA (Leu) (UUR) gene associated with the MELAS subgroup of mitochondrial encephalomyopathies . Nature . 1990;348:651–653
  38. Ciafaloni E , Ricci E , Servidei S , Shanske S , Silvestri G , Manfredi G , et al.   Widespread tissue distribution of a tRNALeu(UUR) mutation in the mitochondrial DNA of a patient with MELAS syndrome . Neurology . 1991;41:1663–1664
  39. Macmillan C , Lach B , Shoubridge EA . Variable distribution of mutant mitochondrial DNAs tRNA(Leu[3243]) in tissues of symptomatic relatives with MELAS: the role of mitotic segregation . Neurology . 1993;43:1586–1590
  40. Fang W , Huang CC , Lee CC , Cheng SY , Pang CY , Wei YH . Ophthalmologic manifestations in MELAS syndrome . Arch Neurol . 1993;50:977–980
  41. Chinnery PF , Howell N , Lightowlers RN , Turnbull DM . Molecular pathology of MELAS and MERRF. The relationship between mutation load and clinical phenotypes . Brain . 1997;120:1713–1721
  42. Zhang Y , Li JF , Wang FY , Li CX . The study of A3243G and G13513A mitochondria DNA point mutation in patients with cerebral infarction . Chin Med J (Beijing) . 2001;114:129–135
  43. Tzen CY , Thajeb P , Wu TY , Chen SC . MELAS with point mutations involving tRNALeu (A3243G) and tRNAGlu (14693G) . Muscle Nerve . 2003;28:575–581
  44. Graf WD , Sumi SM , Copass MK , Ojemann LM , Longstreth WT , Shanske S , et al.   Phenotypic heterogeneity in families with the myoclonic epilepsy and ragged-red fiber disease point mutation in mitochondrial DNA . Ann Neurol . 1993;33:640–645
  45. Silvestri G , Ciafaloni E , Santorelli FM , Shanske S , Servidei S , Graf WD , et al.   Clinical features associated with the A→G transition at nucleotide 8344 of mtDNA (“MERRF mutation”) . Neurology . 1993;43:1200–1206
  46. Tanno Y , Yoneda M , Tanaka K , Kondo R , Hozumi I , Wakabayashi K , et al.   Uniform tissue distribution of tRNA(Lys) mutation in mitochondrial DNA in MERRF patients . Neurology . 1993;43:1198–1200
  47. Shoffner JM , Lott MT , Lezza AM , Seibel P , Ballinger SW , Wallace DC . Myoclonic epilepsy and ragged-red fiber disease (MERRF) is associated with a mitochondrial DNA tRNA Lys mutation . Cell . 1990;61:931–937
  48. Zeviani M , Gellera C , Antozzi C , Rimoldi M , Morandi L , Villani F , et al.   Maternally inherited myopathy and cardiomyopathy: association with mutation in mitochondrial DNA tRNA(Leu)(UUR) . Lancet . 1991;338:143–147
  49. Thajeb P , Ma YS , Tzen CY , Chuang CK , Wu TY , Chen SC , et al.   Oculopharyngeal somatic myopathy in a patient with a novel large-scale 3399bp deletion and a homoplasmic T5814C transition of the mitochondrial DNA . Clin Neurol Neurosurg . 2006;108:407–410
  50. Mattiazzi M , Vijayvergiya C , Gajewski CD , DeVivo DC , Lenaz G , Wiedmann M , et al.   The mtDNA T8993G (NARP) mutation results in an impairment of oxidative phosphorylation that can be improved by antioxidants . Hum Mol Genet . 2004;13:869–879
  51. Pulkes T , Eunson L , Patterson V , Siddiqui A , Wood NW , Nelson IP , et al.   The mitochondrial DNA G13513A transition in ND5 is associated with LHON/MELAS overlap syndrome and may be a frequent cause of MELAS . Ann Neurol . 1999;46:916–919
  52. Campos Y , Martin MA , Lorenzo G , Aparicio M , Cabello A , Arenas J . Sporadic MERRF/MELAS overlap syndrome associated with the 3243 tRNA(Leu(UUR)) mutation of mitochondrial DNA . Muscle Nerve . 1996;19:187–190
  53. Hsu CC , Chuang YH , Tsai JL , Jong HJ , Shen YY , Huang HL , et al.   CPEO and carnitine deficiency overlapping in MELAS syndrome . Acta Neurol Scand . 1995;92:252–255
  54. Hirano M , Silvestri G , Blake DM , Lombes A , Minetti C , Bonilla E , et al.   Mitochondrial neurogastrointestinal encephalomyopathy (MNGIE): clinical, biochemical, and genetic features of an autosomal recessive mitochondrial disorder . Neurology . 1994;44:721–727
  55. Said G , Lacroix C , Plante-Bordeneuve V , Messing B , Slama A , Crenn P , et al.   Clinicopathological aspects of the neuropathy of neurogastrointestinal encephalomyopathy (MNGIE) in four patients including two with a Charcot-Marie-Tooth presentation . J Neurol . 2005;252:655–662
  56. Vissing J , Ravn K , Danielsen ER , Duno M , Wibrand F , Wevers RA , et al.   Multiple mtDNA deletions with features of MNGIE . Neurology . 2002;59:926–929
  57. Wallace DC , Lott MT . Mitochondrial genes in degenerative diseases, cancer and aging . In:  Rimon DL ,  Connor JM ,  Pyeritz RE ,  Korf BR editor. Emery and Rimons's Principles and Practice of Medical Genetics . 4 th edition. London: Churchill Livingstone; 2002;p. 299–409 1
  58. Hammans SR , Sweeney MG , Brockington M , Lennox GG , Lawton NF , Kennedy CR , et al.   The mitochondrial DNA transfer RNA (Lys) A to G (3243) mutation and the syndrome of myoclonic epilepsy with ragged-red fibers (MERRF). Relationship of clinical phenotype to proportion of mutant mitochondrial DNA . Brain . 1993;116:617–632
  59. Tanno Y , Yoneda M , Tanaka K , Tanaka H , Yamazaki M , Nishizawa M , et al.   Quantitation of heteroplasmy of mitochondrial tRNA(Leu(UUR)) gene using PCR-SSCP . Muscle Nerve . 1995;18:1390–1397
  60. Kobayashi Y , Ichihashi K , Ohta S , Nihei K , Kagawa Y , Yanagisawa M , et al.   The mutant mitochondrial genes in mitochondrial myopathy, encephalopathy, lactic acidosis and stroke-like episodes (MELAS) were selectively amplified through generations . J Inherit Metab Dis . 1992;15:803–808
  61. Parry A , Matthews PM . Roles for imaging in understanding the pathophysiology, clinical evaluation, and management of patients with mitochondrial disease . J Neuroimaging . 2003;13:293–302
  62. Engel WK , Cunningham GC . Rapid examination of muscle tissue: an improved trichrome method for freshfrozen biopsy sections . Neurology . 1963;13:919–923
  63. Ogasahara S , Engel AG , Frens D , Mack D . Muscle coenzyme Q deficiency in familial mitochondrial encephalomyopathy . Proc Natl Acad Sci USA . 1989;86:2379–2382
  64. Van Maldergem L , Trijbels F , DiMauro S , Sindelar PJ , Musumeci O , Janssen A , et al.   Coenzyme Q-responsive Leigh's encephalopathy in two sisters . Ann Neurol . 2002;52:750–754
  65. Dalakas MC , Illa I , Pezeshkpour GH , Laukaitis JP , Cohen B , Griffin JL . Mitochondrial myopathy caused by long-term zidovudine therapy . N Engl J Med . 1990;322:1098–1105
  66. Hanzlikova V , Schiaffino S . Mitochondrial changes in ischemic skeletal muscle . J Ultrastruct Res . 1977;60:121–133
  67. Shy GM , Gonatas NK . Human myopathy with giant abnormal mitochondria . Science . 1964;145:493–496
  68. Shy GM , Gonatas NK , Perez M . Two childhood myopathies with abnormal mitochondria: I. Megoconial myopathy. II. Pleoconial myopathy . Brain . 1966;89:133–158
  69. Bonilla E , Schotland DL , DiMauro S , Aldover B . Electron cytochemistry of crystalline inclusions in human skeletal muscle mitochondria . J Ultrastruct Res . 1975;51:404–408

PII: S1873-9598(08)70020-6

doi:10.1016/S1873-9598(08)70020-6

International Journal of Gerontology
Volume 1, Issue 1 , Pages 22-30, March 2007

Article Tools